Intracranial Aneurysm Rupture Status and Metabolic Syndrome in a Treated Cohort

A single-center retrospective cohort analysis of 828 patients with intracranial aneurysms who underwent endovascular treatment at Wenzhou Central Hospital between January 2018 and January 2024. The dataset includes 484 unruptured and 344 ruptured aneurysms, examining associations between metabolic syndrome (MetS) and aneurysm rupture status. It was created by Zisheng Liu and last updated in May 2026.

Use Cases

• Predicting aneurysm rupture risk based on metabolic syndrome components mentioned in the description
• Analyzing the association between individual metabolic markers (e.g., glucose, HDL cholesterol) and vascular outcomes
• Training models to identify high-risk patient profiles for targeted intervention
• Conducting sensitivity analyses on clinical data with imaging subsamples

Strengths

• Dataset includes 828 patient records with a clear split of 344 ruptured and 484 unruptured aneurysms.
• Analysis includes a 400-patient imaging subsample for morphology-adjusted sensitivity.
• Results report specific adjusted odds ratios (e.g., 1.83 for binary MetS) and model AUC (0.711).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the primary data file is unknown, which may limit suitability assessment.
• Data is from a single center (Wenzhou Central Hospital), which may limit generalizability.

Provenance

Source

figshare

Collection Method

Retrospective cohort analysis of hospital records.

Time Range

January 2018 to January 2024

Freshness

Last updated 2026-05-22 04:28:06.

Geography

Wenzhou Central Hospital, China